健康科技
保加利亚公司 developing health technologies
医疗器械、诊断产品及医疗保健软件平台的开发构成了健康科技行业的核心。监管审批的时间节点以及不断变化的联邦医疗保险报销模式，持续为相关股票注入流动性。目前，Sopharma AD在交易量方面占据主导地位，而Synthetica AD则记录了最强劲的24小时表现。下表汇总了关键的技术面与基本面数据。
商品代码 | 总市值 | 价格 | 涨跌 % | 成交量 | 相对成交量 | P/E | 摊薄每股收益 净利率，TTM | 每股收益缓慢增长 TTM同比 | 股息收益率 % 净利率，TTM | 分析师评级 |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 1.19 T EUR | 1,228.4 EUR | −4.60% | 0 | — | 45.72 | 26.87 EUR | +55.94% | 0.47% | 强烈买入 |
 JNJJohnson & Johnson | 592.45 B EUR | 243.05 EUR | −2.88% | 0 | — | 41.77 | 5.82 EUR | −34.10% | 1.91% | 买入 |
 4ABAbbVie, Inc. | 464.16 B EUR | 258.10 EUR | −3.44% | 0 | — | 50.32 | 5.13 EUR | +354.14% | 2.35% | 买入 |
 6MKMerck & Co., Inc. | 330.4 B EUR | 131.38 EUR | −3.35% | 0 | — | 151.99 | 0.86 EUR | −86.58% | 2.26% | 买入 |
 ZEGAstraZeneca PLC | 260.84 B EUR | 165.60 EUR | −3.36% | 0 | — | 26.86 | 6.17 EUR | +16.68% | 1.70% | 买入 |
 ABLAbbott Laboratories | 178.02 B EUR | 99.54 EUR | −4.29% | 0 | — | 41.63 | 2.39 EUR | −64.81% | 2.18% | 买入 |
 NOVNovo Nordisk A/S Class B | 168.68 B EUR | 35.975 EUR | −1.73% | 16 | 0.52 | 10.58 | 3.40 EUR | +9.26% | 4.10% | 中立 |
 PFEPfizer Inc. | 156.31 B EUR | 28.005 EUR | +3.47% | 0 | 0.00 | 45.37 | 0.62 EUR | −57.78% | 5.59% | 中立 |
 2M6Medtronic Plc | 119.58 B EUR | 92.16 EUR | −2.41% | 0 | — | 26.14 | 3.53 EUR | +11.12% | 2.72% | 买入 |
 SYKStryker Corporation | 115.16 B EUR | 277.5 EUR | −0.89% | 0 | — | 33.49 | 8.29 EUR | +27.68% | 1.04% | 买入 |
 SNWSanofi SA | 100.88 B EUR | 82.86 EUR | −2.38% | 0 | 0.00 | 24.89 | 3.33 EUR | −35.60% | 4.90% | 买入 |
 0QFModerna, Inc. | 91.88 B EUR | 194.700 EUR | −1.54% | 0 | — | — | −6.99 EUR | −9.55% | 0.00% | 中立 |
 ESLEssilorLuxottica SA | 87.56 B EUR | 192.70 EUR | +0.05% | 0 | — | 36.01 | 5.35 EUR | +3.83% | 2.12% | 买入 |
 MRKMerck KGaA | 65.41 B EUR | 147.95 EUR | −1.14% | 0 | — | 27.14 | 5.45 EUR | −17.22% | 1.46% | 买入 |
 BSXBoston Scientific Corporation | 59.15 B EUR | 40.860 EUR | +0.26% | 0 | — | 19.60 | 2.09 EUR | +30.86% | 0.00% | 买入 |
 BAYNBayer AG | 53.29 B EUR | 54.52 EUR | −3.26% | 0 | 0.00 | — | −1.77 EUR | +49.15% | 0.20% | 买入 |
 SHLSiemens Healthineers AG | 50.04 B EUR | 44.28 EUR | −1.18% | 0 | 0.00 | 22.43 | 1.97 EUR | +2.35% | 2.23% | 买入 |
 ZOEZoetis, Inc. Class A | 32.83 B EUR | 76.60 EUR | +0.21% | 0 | — | 14.39 | 5.32 EUR | +7.88% | 2.38% | 中立 |
 KN8Krka, d. d., Novo mesto | 7.73 B EUR | 244.0 EUR | −2.01% | 0 | — | 17.73 | 13.77 EUR | +10.70% | 3.67% | 买入 |
 AFXCarl Zeiss Meditec AG | 3.2 B EUR | 34.98 EUR | −3.05% | 0 | — | 32.28 | 1.08 EUR | −38.81% | 1.54% | 卖出 |
 SFASopharma AD | 1.68 B EUR | 3.33 EUR | +0.91% | 16.3 K | 0.36 | 22.29 | 0.15 EUR | +52.60% | 2.97% | 尚无评分 |
 NVV1Novavax, Inc. | 1.56 B EUR | 9.27 EUR | +2.54% | 0 | — | — | −1.33 EUR | −169.59% | 0.00% | 买入 |
 038NovoCure Ltd. | 1.52 B EUR | 12.150 EUR | +1.63% | 0 | — | — | −0.94 EUR | +31.50% | 0.00% | 买入 |
 EUZEckert & Ziegler SE | 876.04 M EUR | 13.80 EUR | −2.89% | 0 | — | 17.44 | 0.79 EUR | +35.27% | 1.57% | 强烈买入 |
 AYJValneva SE | 481.73 M EUR | 2.479 EUR | −2.32% | 0 | — | — | −0.90 EUR | −117.39% | 0.00% | 强烈买入 |
| SSYNSynthetica AD | 154.5 M EUR | 51.5 EUR | +11.96% | 3 | 0.02 | 33.27 | 1.55 EUR | +879.62% | 0.00% | 尚无评分 |
| EETREtropal AD | 15 M EUR | 3.00 EUR | 0.00% | 40 | 1.25 | — | −0.02 EUR | −253.70% | 0.00% | 尚无评分 |
 PHRMPharmhold AD | — | 0.540 EUR | 0.00% | 0 | — | — | — | — | — | 尚无评分 |